Columnist Jolie Lizana writes about techniques she uses to keep bad feelings at bay and remember the good moments in her life ...

Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new ...

The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and ...

Constantly being attached to home medical devices is overwhelming, but columnist Anna Jeter is also grateful for the ...

People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

Tiakis Biotech is preparing for a Phase 2 U.S. trial of tiprelestat for PAH after completing a data package required for ...

Scientists found altered activity of the PUM1 protein plays a key role in pulmonary hypertension development, making it a PH ...

This article is provided by our partner, the American Lung Association. It has been reviewed by Bionews for accuracy and relevance. The views and opinions expressed are those of the author and do not ...

CM5480, an experimental therapy being developed by Calcimedica, improved blood flow and heart-function measures in a rat model of pulmonary arterial hypertension (PAH), a new study reports. The ...

Pulmonary hypertension (PH) is a rare, chronic, progressive disease characterized by high blood pressure in the blood vessels of the lungs, known as the pulmonary arteries. The World Health ...